Quantcast

Latest Medical therapy Stories

2012-02-28 14:48:00

A meta-analysis of eight previously published clinical trials suggests that initial stent implantation for patients with stable coronary artery disease is not associated with improved outcomes compared with initial medical therapy for prevention of death, nonfatal heart attacks, unplanned revascularization or angina, according to a study published in the Feb. 27 Archives of Internal Medicine, one of the JAMA/Archives journals. The article is part of the journal's Less is More series. While...

2011-05-13 07:49:02

(Ivanhoe Newswire) -- Physicians are struggling to translate clinical research into everyday practice. A new study shows that medical therapy from a widely publicized clinical trial was applied less than half the time to heart stent patients. Researchers from NewYork-Presbyterian Hospital/Weill Cornell Medical Center reviewed almost 500,000 cardiac cases across the country. They found that medical therapy given to patients who received a heart stent improved less than three percent as a...

2011-05-11 00:57:50

Despite guideline-based recommendations that underscore the importance of optimal medical therapy (OMT) for patients with stable coronary heart disease undergoing percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries), data from a cardiovascular registry indicate that less than half of these patients are receiving OMT before PCI and approximately one-third are not receiving OMT at discharge following PCI,...

2008-09-11 12:00:43

Cook Medical has completed enrollment in the first international clinical trial of a new drug-eluting stent designed to treat arterial blockages outside the coronary arteries. The 420 patients enrolled in Cook's randomized trial of its Zilver PTX drug-eluting peripheral stent include peripheral arterial disease patients treated in Germany, the US and Japan. The Zilver PTX trial was designed to determine whether the combination of Cook's Zilver stent and a paclitaxel coating will keep...

2008-07-14 09:00:31

Micrus Endovascular has announced that the Vitesse intracranial stent study for ischemic therapy clinical trial application has received conditional approved from the FDA. The Pharos Vitesse intracranial stent is Micrus Endovascular's second balloon-expandable stent for the treatment of intracranial ischemic stenosis and is the subject of an investigational device exemption (IDE) study designed to compare the clinical outcomes between patients treated with the stent and another medical...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related